MedX Health Corp MDX.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -34.82% | 28.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -34.82% | 28.70% | |||
| Cost of Revenue | -36.87% | -60.83% | |||
| Gross Profit | -30.80% | 139.79% | |||
| SG&A Expenses | 21.66% | -14.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 19.64% | -21.96% | |||
| Operating Income | -30.20% | 27.51% | |||
| Income Before Tax | -28.25% | 41.02% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -28.25% | 41.02% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.25% | 41.02% | |||
| EBIT | -30.20% | 27.51% | |||
| EBITDA | -28.59% | 63.05% | |||
| EPS Basic | -25.93% | 42.55% | |||
| Normalized Basic EPS | -29.41% | 34.62% | |||
| EPS Diluted | -25.93% | 42.55% | |||
| Normalized Diluted EPS | -29.41% | 34.62% | |||
| Average Basic Shares Outstanding | 0.00% | 2.43% | |||
| Average Diluted Shares Outstanding | 0.00% | 2.43% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||